Emin Araftpoor is a doctoral researcher at the VIB-UGent Center for Medical Biotechnology, affiliated with the Gevaert Lab at Ghent University. Supported by a fellowship from the Research Foundation—Flanders (FWO), his work focuses on advancing single-cell proteomics (SCP) to investigate cellular heterogeneity in cancer, particularly in melanoma. By employing mass spectrometry-based SCP, he aims to directly measure protein abundances at the single-cell level, providing insights into drug targets and oncogenic pathways beyond what transcriptomic analyses can reveal. Emin's academic background includes a Bachelor and Master of Science in Biochemistry and Biotechnology from Ghent University, completed in 2021 and 2023, respectively. His research contributes to the refinement of SCP workflows, facilitating their application in cancer research. Notably, he co-authored a study exploring proteomic signatures in bull fertility, linking sperm protein profiles to embryo development outcomes. Through his work, Emin Araftpoor is at the forefront of integrating proteomic technologies into biomedical research, aiming to enhance our understanding of disease mechanisms and improve therapeutic strategies.
Emin Araftpoor is a doctoral researcher at the VIB-UGent Center for Medical Biotechnology, affiliated with the Gevaert Lab at Ghent University. Supported by a fellowship from the Research Foundation—Flanders (FWO), his work focuses on advancing single-cell proteomics (SCP) to investigate cellular heterogeneity in cancer, particularly in melanoma. By employing mass spectrometry-based SCP, he aims to directly measure protein abundances at the single-cell level, providing insights into drug targets and oncogenic pathways beyond what transcriptomic analyses can reveal. Emin's academic background includes a Bachelor and Master of Science in Biochemistry and Biotechnology from Ghent University, completed in 2021 and 2023, respectively. His research contributes to the refinement of SCP workflows, facilitating their application in cancer research. Notably, he co-authored a study exploring proteomic signatures in bull fertility, linking sperm protein profiles to embryo development outcomes. Through his work, Emin Araftpoor is at the forefront of integrating proteomic technologies into biomedical research, aiming to enhance our understanding of disease mechanisms and improve therapeutic strategies.